Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.
about
Clinical applications of mouse models for breast cancer engaging HER2/neu.Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α.20(S)-Protopanaxadiol-Induced Apoptosis in MCF-7 Breast Cancer Cell Line through the Inhibition of PI3K/AKT/mTOR Signaling Pathway.Novel treatment strategies for patients with HER2-positive breast cancer who do not benefit from current targeted therapy drugs
P2860
Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.
@en
type
label
Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.
@en
prefLabel
Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.
@en
P2093
P2860
P356
P1476
Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.
@en
P2093
Elizabeth A Fry
Kazushi Inoue
Pankaj Taneja
P2860
P304
P356
10.1002/IJC.30399
P577
2016-09-12T00:00:00Z